Top Markets
#1 Black Phoenix Black Phoenix +21,667.50%
#2 Nesa Nesa +771.34%
#3 Kinesis Silver Kinesis Silver +55.36%
#4 QuantixAI QuantixAI +23.76%
#5 Cash Cat Cash Cat +22.87%
#6 EXOD EXOD +22.78%
#7 Pons Pons +22.41%
#8 Alchemist AI Alchemist AI +16.62%
#9 Derive Derive +15.54%
#10 BNB Attestation Service BNB Attestation Service +15.18%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Gedeon Richter PLC Gedeon Richter PLC

Gedeon Richter PLC

GEDSF
Classifica tra le azioni #3863
Gedeon Richter Plc is a company focused on the development and manufacturing of... Gedeon Richter Plc is a company focused on the development and manufacturing of pharmaceutical products. Its operations are organized into three primary divisions: Pharmaceuticals, Wholesale & Retail, and Other. The Pharmaceutical segment covers all aspects from the research and development of new drugs and their production, through to their sales and marketing. The Wholesale & Retail division is responsible for distributing the company's products to consumers via its network of affiliated companies and pharmacies across various regional markets. The Other segment includes services provided by group members that support marketing and sales activities. The company was established in 1901 by Gedeon Richter and is headquartered in Budapest, Hungary.
Prezzo delle azioni
$24.85
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$4.54B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
HU
Scambia Gedeon Richter PLC (GEDSF)

Categoria

Healthcare
Utile per Gedeon Richter PLC (GEDSF)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Gedeon Richter PLC, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Gedeon Richter PLC dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK